Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Pembrolizumab With Intratumoral Injection of Clostridium Novyi-NT

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03435952
Recruitment Status : Recruiting
First Posted : February 19, 2018
Last Update Posted : April 25, 2022
Sponsor:
Collaborators:
BioMed Valley Discoveries, Inc
Merck Sharp & Dohme LLC
Information provided by (Responsible Party):
M.D. Anderson Cancer Center

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : October 1, 2024
Estimated Study Completion Date : October 1, 2024